JW Holdings Corporation (096760.KS)
KRW 3045.0
(0.0%)
KRW 3045.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1176.26 Billion KRW | 1.61% |
| 2022 | 1157.57 Billion KRW | 8.61% |
| 2021 | 1065.77 Billion KRW | -4.29% |
| 2020 | 1113.57 Billion KRW | -10.45% |
| 2019 | 1243.46 Billion KRW | -2.52% |
| 2018 | 1275.63 Billion KRW | -5.6% |
| 2017 | 1351.37 Billion KRW | 12.93% |
| 2016 | 1196.62 Billion KRW | 10.51% |
| 2015 | 1082.86 Billion KRW | 4.52% |
| 2014 | 1036 Billion KRW | 2.13% |
| 2013 | 1014.44 Billion KRW | -5.82% |
| 2012 | 1077.13 Billion KRW | -1.61% |
| 2011 | 1094.78 Billion KRW | 10.18% |
| 2010 | 993.62 Billion KRW | 40.02% |
| 2009 | 709.63 Billion KRW | 10.52% |
| 2008 | 642.08 Billion KRW | 15.71% |
| 2007 | 554.89 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1189.82 Billion KRW | 1.15% |
| 2024 Q2 | 1207.54 Billion KRW | 1.49% |
| 2023 Q4 | 1176.26 Billion KRW | -2.42% |
| 2023 Q3 | 1205.45 Billion KRW | 1.73% |
| 2023 Q2 | 1184.97 Billion KRW | -4.75% |
| 2023 FY | 1176.26 Billion KRW | 1.61% |
| 2023 Q1 | 1244.11 Billion KRW | 7.48% |
| 2022 Q2 | 1111.17 Billion KRW | 1.97% |
| 2022 Q3 | 1128.22 Billion KRW | 1.53% |
| 2022 Q4 | 1157.57 Billion KRW | 2.6% |
| 2022 Q1 | 1089.66 Billion KRW | 2.24% |
| 2022 FY | 1157.57 Billion KRW | 8.61% |
| 2021 FY | 1065.77 Billion KRW | -4.29% |
| 2021 Q3 | 1060.29 Billion KRW | 1.19% |
| 2021 Q2 | 1047.83 Billion KRW | -3.12% |
| 2021 Q1 | 1081.57 Billion KRW | -2.87% |
| 2021 Q4 | 1065.77 Billion KRW | 0.52% |
| 2020 Q4 | 1113.57 Billion KRW | -7.46% |
| 2020 Q1 | 1223.42 Billion KRW | -1.61% |
| 2020 FY | 1113.57 Billion KRW | -10.45% |
| 2020 Q2 | 1199.45 Billion KRW | -1.96% |
| 2020 Q3 | 1203.3 Billion KRW | 0.32% |
| 2019 Q1 | 1261.22 Billion KRW | -1.13% |
| 2019 Q3 | 1233.04 Billion KRW | -0.97% |
| 2019 FY | 1243.46 Billion KRW | -2.52% |
| 2019 Q2 | 1245.09 Billion KRW | -1.28% |
| 2019 Q4 | 1243.46 Billion KRW | 0.84% |
| 2018 Q4 | 1275.63 Billion KRW | -3.63% |
| 2018 Q3 | 1323.69 Billion KRW | -5.5% |
| 2018 Q2 | 1400.8 Billion KRW | 2.95% |
| 2018 Q1 | 1360.6 Billion KRW | 0.68% |
| 2018 FY | 1275.63 Billion KRW | -5.6% |
| 2017 Q2 | 1290.07 Billion KRW | 0.99% |
| 2017 Q4 | 1351.37 Billion KRW | -0.94% |
| 2017 FY | 1351.37 Billion KRW | 12.93% |
| 2017 Q3 | 1364.24 Billion KRW | 5.75% |
| 2017 Q1 | 1277.42 Billion KRW | 6.75% |
| 2016 Q3 | 1148.48 Billion KRW | 2.48% |
| 2016 FY | 1196.62 Billion KRW | 10.51% |
| 2016 Q1 | 1115.9 Billion KRW | 3.05% |
| 2016 Q4 | 1196.62 Billion KRW | 4.19% |
| 2016 Q2 | 1120.72 Billion KRW | 0.43% |
| 2015 Q4 | 1082.86 Billion KRW | -1.34% |
| 2015 FY | 1082.86 Billion KRW | 4.52% |
| 2015 Q3 | 1097.59 Billion KRW | 1.46% |
| 2015 Q2 | 1081.79 Billion KRW | 3.63% |
| 2015 Q1 | 1043.94 Billion KRW | 0.77% |
| 2014 Q4 | 1036 Billion KRW | -0.38% |
| 2014 Q3 | 1039.94 Billion KRW | 0.9% |
| 2014 FY | 1036 Billion KRW | 2.13% |
| 2014 Q1 | 1034.98 Billion KRW | 2.02% |
| 2014 Q2 | 1030.68 Billion KRW | -0.41% |
| 2013 Q3 | 1010.17 Billion KRW | 2.11% |
| 2013 Q4 | 1014.44 Billion KRW | 0.42% |
| 2013 FY | 1014.44 Billion KRW | -5.82% |
| 2013 Q1 | 1106.01 Billion KRW | 2.68% |
| 2013 Q2 | 989.33 Billion KRW | -10.55% |
| 2012 FY | 1077.13 Billion KRW | -1.61% |
| 2012 Q4 | 1077.13 Billion KRW | 0.0% |
| 2011 Q3 | 209.14 Billion KRW | 2.54% |
| 2011 Q1 | 199.15 Billion KRW | 0.0% |
| 2011 Q2 | 203.95 Billion KRW | 2.41% |
| 2011 FY | 1094.78 Billion KRW | 10.18% |
| 2010 Q3 | 172.02 Billion KRW | 3.96% |
| 2010 Q2 | 165.48 Billion KRW | -0.2% |
| 2010 Q1 | 165.81 Billion KRW | 0.0% |
| 2010 FY | 993.62 Billion KRW | 40.02% |
| 2009 Q3 | 163.51 Billion KRW | -5.65% |
| 2009 Q1 | 155.92 Billion KRW | 0.0% |
| 2009 FY | 709.63 Billion KRW | 10.52% |
| 2009 Q2 | 173.3 Billion KRW | 11.14% |
| 2008 Q1 | 135.29 Billion KRW | 0.0% |
| 2008 Q2 | 142.92 Billion KRW | 5.64% |
| 2008 FY | 642.08 Billion KRW | 15.71% |
| 2008 Q3 | 149.98 Billion KRW | 4.94% |
| 2007 Q3 | 89.91 Billion KRW | 0.0% |
| 2007 FY | 554.89 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -493.434% |
| Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | 39.898% |
| Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -34.124% |
| HANDOK Inc. | 790.33 Billion KRW | -48.83% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -589.407% |
| Yuhan Corporation | 2814.07 Billion KRW | 58.201% |
| Dong-A ST Co., Ltd. | 1315.21 Billion KRW | 10.565% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -1158.321% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | 39.742% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -390.628% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -150.855% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -923.078% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -397.262% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -237.633% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -493.434% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -180.605% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -135.359% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -99.571% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -92.433% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | 16.126% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -82.356% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -235.996% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -663.606% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -217.327% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -141.371% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -493.434% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | -9.109% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | 33.556% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -82.356% |
| Yuhan Corporation | 2814.07 Billion KRW | 58.201% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | -33.667% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -419.092% |
| Suheung Co., Ltd. | 993.73 Billion KRW | -18.368% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -82.356% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -180.129% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -150.878% |
| CKD Bio Corp. | 293.78 Billion KRW | -300.383% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -131.549% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -108.199% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -193.168% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -235.996% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | 19.213% |
| Boryung Corporation | 922.36 Billion KRW | -27.528% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -165.846% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -150.855% |
| JW Lifescience Corporation | 255.83 Billion KRW | -359.773% |